http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007069264-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81075572b8d1526ce20dbf5dd7dbded8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba82ef54f5c7314ff623f52383226cc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41d06cd6a008636eb5564c2b62cb7839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36aa36f0b5173efc54236c766421edfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc41c00f17715b2b1dbe58d49c9c0a70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65e0a5c0c77fdc8c9d1649e7ca2ded39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a43efc9cd2b8321c0c8bd228e54b83d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
filingDate 2006-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13067ec0407ebd9fa7d77a2bb54083f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc489979e77607f9d3c0edd43dae03c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c76dc91b66710a1ae261d55f3db89ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_342d10ce82fc282b93e8ae15d6497490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5c260b8211c897d65d50de0dd1c81f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfff94d5fde313bbf31a3a509df6d7dc
publicationDate 2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007069264-A3
titleOfInvention Reference standards for determining the purity of telithromycin and processes therefor
abstract A method of testing the purity of a sample of Telithromycin or a pharmaceutical dosage form comprising Telithromycin, which method comprises assaying the said sample for the presence of compound A, B and D, wherein compound A is represented by following structural formula (I); Compound A compound B is represented by following structural formula (II); and compound B and compound D is represented by following structural formula (III) and the compounds A, B and D as well as their uses as reference markers for testing the purity of a sample of Telithromycin or a pharmaceutical dosage form comprising Telithromycin.
priorityDate 2005-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02054062-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9731929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1170588-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005108984-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005105821-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17753754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3002190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396929

Total number of triples: 33.